The analysis of BRAF fusions characteristics in Chinese solid tumor patients.

被引：0
|
作者：
Ma, Fang
Zhao, Yaping
Wang, Chenxi
Han, Tiantian
Ding, Ran
Deng, Wanglong
Bu, Fanfeng
机构：
[1] Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China
[2] Nanjing Simcere Med Lab Sci Co Ltd, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15073
引用
收藏
页数：1
相关论文
共 50 条
  • [21] BRAF Fusions in Histiocytic Disorders: Frequency and Clinical Characteristics
    Zanwar, Saurabh
    Abeykoon, Jithma P.
    Acosta-Medina, Aldo A.
    Ravindran, Aishwarya
    Rech, Karen
    Schwartz, Jonathan
    Bennani, Nora
    Shah, Mithun V.
    Morlote, Diana
    Goyal, Gaurav
    Go, Ronald
    BLOOD, 2021, 138
  • [22] Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets
    Chen, Monica F.
    Yang, Soo-Ryum
    Tao, Jessica J.
    Desilets, Antoine
    Diamond, Eli L.
    Wilhelm, Clare
    Rosen, Ezra
    Gong, Yixiao
    Mullaney, Kerry
    Torrisi, Jean
    Young, Robert J.
    Somwar, Romel
    Yu, Helena A.
    Kris, Mark G.
    Riely, Gregory J.
    Arcila, Maria E.
    Ladanyi, Marc
    Donoghue, Mark T. A.
    Rosen, Neal
    Yaeger, Rona
    Drilon, Alexander
    Murciano-Goroff, Yonina R.
    Offin, Michael
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3812 - 3823
  • [23] Pharmacokinetic study of aldoxorubicin in solid tumor patients.
    Mite, Monica M.
    Natale, Ronald B.
    Wolin, Edward M.
    Dinh, Hillary
    Wieland, Scott
    Levitt, Daniel J.
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Pharmacokinetic study of aldoxorubicin in solid tumor patients.
    Natale, Ronald B.
    Mita, Alain C.
    Wolin, Edward M.
    Laabs, Brenda
    Dinh, Hillary
    Wieland, Scott
    Levitt, Daniel
    Mita, Monica M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Landscape of RB1 alterations in 22,432 Chinese solid tumor patients.
    Wang, Nan
    She, Xueke
    Huang, Depei
    Shen, Xudong
    Zhang, Hushan
    Ji, Gang
    CANCER RESEARCH, 2021, 81 (13)
  • [26] Beyond KIAA1549::BRAF: Rare and Novel BRAF Fusions Identified in Solid Tumors
    Guseva, N.
    Stence, A.
    Sompallae, R.
    Hornberg, S.
    Snow, A.
    Bhagavathi, S.
    Bossler, A.
    Ma, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S121 - S121
  • [27] The characteristics in Chinese NSCLC patients with different BRAF mutation classes
    Wang, Q.
    Fu, D.
    Li, X.
    Zhang, L.
    Dong, X.
    Pang, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S236 - S236
  • [28] Detecting NTRK, ROS1, and ALK gene fusions in gastrointestinal tumor patients.
    Potts, Steven James
    Dean, Emma Jane
    Polikoff, Jonathan
    Pacey, Simon
    Chiorean, E. Gabriela
    Chee, Chong Ean
    Sigal, Darren
    Aslam, Maria
    Pauwels, Patrick
    Christiansen, Jason H.
    Multani, Pratik S.
    Lamoureux, Jennifer
    Murphy, Danielle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [29] Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors
    Guan, Yin
    Wang, Yutong
    Li, Hongxia
    Meng, Jing
    You, Xia
    Zhu, Xiaofeng
    Zhang, Qin
    Sun, Tingting
    Qi, Chuang
    An, Guangyu
    Fan, Ying
    Xu, Binghe
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Characteristics of EGFR uncommon mutations in Chinese cancer patients.
    Wang, Minghui
    Li, Shuben
    Wang, Hongbiao
    Xie, Jianjiang
    Zhang, Junhang
    Li, Yun
    Li, Kunsong
    Huang, Jian
    Cheng, Chunyan
    Wang, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345